Abstract:Abstract Background Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti- M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti- M. hyopneumoniae IgG in inactivated bacterin-induced hyperimmune sera and convalescent sera resulting from natural M. hyopneumoniae infection. Establishment of an ELISA to detect anti- M. hyopneumoniae IgG in convalescent sera will facilitate the evaluation of the M. hyopneumoniae status of pig farms. Results In this study, we expressed and purified recombinant Mhp366-N protein, which contains an epitope recognized by M. hyopneumoniae convalescent sera but not hyperimmune sera, for use as a coating antigen. For the M. hyopneumoniae convalescent serum IgG-ELISA, the optimal antigen concentration, blocking buffer, blocking time, dilution of serum, incubation time with serum, secondary antibody dilution, secondary antibody incubation time and colorimetric reaction time were 0.25 μg/mL, 2.5 % skim milk, 1 h, 1:500, 0.5 h, 1:10,000, 1 h and 15 min, respectively. Validation of the M. hyopneumoniae convalescent serum IgG-ELISA showed a cut-off value of 0.323, the intra-assay CV ranged from 3.27 to 7.26 %, the inter-assay CV ranged from 3.46 to 5.93 %, and the assay was able to differentiate convalescent sera from antibodies to 7 other porcine respiratory pathogens. The convalescent serum IgG-ELISA detected no anti- M. hyopneumoniae IgG in hyperimmune serum samples while a commercial IgG-ELISA identified 95/145 of these sera as positive. The accuracy of the M. hyopneumoniae convalescent serum IgG-ELISA was comparable to the sIgA-ELISA but better than the commercial IgG-ELISA. Conclusions The convalescent serum IgG-ELISA is a reproducible, sensitive, and specific indirect ELISA to detect anti- M. hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera. This ELISA could be used to carry out large scale surveillance of M. hyopneumoniae infection in pig farms regardless of vaccination status.

Development of Indirect ELISA with Recombinant Protein As Antigen

Establishment of an Indirect ELISA for Detection of Antibody Against Goose Circovirus

Development of an Indirect-Elisa for Detecting Specific Antibody to F41 Pilus Protein of Enterotoxigenic Escherichia Coli

Development Of An Indirect Elisa Using Recombinant Omph Protein For Serological Detection Of Riemerella Anatipestifer Infection In Ducks

The Development of ELISA for Detecting Antibody of Pasteurella Multocida in Chicken

Development of an Indirect ELISA Method for Detecting Antibody Against Porcine Epidemic Diarrhea Virus Based on Recombinant N Protein

Detection of Cryptosporidium Parvum Specific Antibodies in Animals by Indirect ELISA

Development of a Blocking ELISA for Detection of Mycoplasma Hyopneumoniae Infection Based on a Monoclonal Antibody Against Protein P65.

Evaluation of a recombinant excretory secretory Haemonchus contortus protein for use in a diagnostic enzyme-linked immunosorbent assay.

Development and Evaluation of an Indirect ELISA Based on Recombinant Nonstructural Protein 3A to Detect Antibodies to Duck Hepatitis A Virus Type 1.

Establishment of indirect ELISA for detection of antibodies against Mycoplasma hyopneumoniae P36 protein.

Prokaryotic expression of the ES24 gene of Haemonchus contortus and its potential application in immunodiagnosis

Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera

Generation and Characterization of Specific Chicken Egg Yolk Immunoglobulins Against Nucleocapsid Protein of Porcine Reproductive and Respiratory Syndrome Virus

Recombinant Multiepitope Protein for Diagnosis of Leptospirosis

Development of a Unique Sandwich Enzyme-Linked Immunosorbent Assay Based on Monoclonal Antibodies for the Specific Detection of the Egg Drop Syndrome Virus.

Development of Indirect ELISA Using Recombinant PCV2 ORF2 Protein As Antigen of Porcine Circovirus 2

Development of an indirect ELISA against Orf virus using two recombinant antigens, partial B2L and F1L

Development of indirect ELISA diagnostic kit for detecting antibody against porcine reproductive and respiratory sydrome virus(PRRSV)

Development of ELISA Using Recombinant Proteins for the Diagnosis of Mycoplasma hyopneumoniae Infection

Development and Application of PPA-ELISA for Detecting Antibodies to Classical Swine Fever Virus Using Recombinant E2 Antigen